Yasmeen Rahimi
Stock Analyst at Piper Sandler
(4.35)
# 1,472
Out of 4,666 analysts
78
Total ratings
46.55%
Success rate
23.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UPB Upstream Bio | Initiates: Overweight | $75 | $18.01 | +316.44% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $7 | $1.00 | +600.00% | 1 | Nov 4, 2024 | |
| SAGE Sage Therapeutics | Reiterates: Overweight | $52 → $26 | $4.91 | +429.53% | 2 | Oct 30, 2024 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $48 → $51 | $31.95 | +59.62% | 3 | Oct 11, 2024 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Overweight | $37 | $20.01 | +84.91% | 2 | Sep 23, 2024 | |
| ZURA Zura Bio | Maintains: Overweight | $26 | $2.90 | +796.55% | 2 | Sep 19, 2024 | |
| SLRN Acelyrin | Maintains: Overweight | $68 → $20 | $4.43 | +351.47% | 2 | Aug 14, 2024 | |
| IMUX Immunic | Reiterates: Overweight | $28 | $1.07 | +2,516.82% | 3 | Jul 16, 2024 | |
| CRNX Crinetics Pharmaceuticals | Maintains: Overweight | $97 | $56.07 | +73.00% | 4 | Jul 2, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $270 | $73.68 | +266.45% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $44.03 | +72.61% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $8.05 | +210.56% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $10.66 | +181.43% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $5.48 | +118.98% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $36 | $38.85 | -7.34% | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.51 | +1,666.78% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $47.00 | +282.98% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.70 | +2,053.63% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $317.09 | +5.96% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $3.13 | +411.18% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $20.31 | +293.89% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $54.83 | +69.62% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $32.71 | +184.32% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $24.00 | +170.83% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $26.17 | +117.81% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $4.52 | +1,382.30% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $40.65 | -13.90% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $22 | $0.94 | +2,242.42% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $9.08 | +858.15% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $94 | $14.40 | +552.78% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $18.20 | +861.54% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $0.81 | +1,138.54% | 1 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $49.86 | +44.40% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $12.73 | +112.10% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $7.98 | +138.10% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $1.72 | +2,806.98% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $2.22 | +1,701.80% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.61 | +2,861.50% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $0.49 | +4,147.57% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $16.17 | +376.19% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $4.32 | +501.85% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $43.69 | +76.24% | 1 | Jul 31, 2020 |
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $18.01
Upside: +316.44%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $7
Current: $1.00
Upside: +600.00%
Sage Therapeutics
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $4.91
Upside: +429.53%
Edgewise Therapeutics
Oct 11, 2024
Maintains: Overweight
Price Target: $48 → $51
Current: $31.95
Upside: +59.62%
NewAmsterdam Pharma Company
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $20.01
Upside: +84.91%
Zura Bio
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $2.90
Upside: +796.55%
Acelyrin
Aug 14, 2024
Maintains: Overweight
Price Target: $68 → $20
Current: $4.43
Upside: +351.47%
Immunic
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $1.07
Upside: +2,516.82%
Crinetics Pharmaceuticals
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $56.07
Upside: +73.00%
Praxis Precision Medicines
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $73.68
Upside: +266.45%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $44.03
Upside: +72.61%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $8.05
Upside: +210.56%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $10.66
Upside: +181.43%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $5.48
Upside: +118.98%
Apr 16, 2024
Maintains: Overweight
Price Target: $31 → $36
Current: $38.85
Upside: -7.34%
Apr 4, 2024
Initiates: Overweight
Price Target: $9
Current: $0.51
Upside: +1,666.78%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $47.00
Upside: +282.98%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.70
Upside: +2,053.63%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $317.09
Upside: +5.96%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $3.13
Upside: +411.18%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $20.31
Upside: +293.89%
Feb 5, 2024
Initiates: Overweight
Price Target: $93
Current: $54.83
Upside: +69.62%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $32.71
Upside: +184.32%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $24.00
Upside: +170.83%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $26.17
Upside: +117.81%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $4.52
Upside: +1,382.30%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $40.65
Upside: -13.90%
Mar 7, 2023
Initiates: Overweight
Price Target: $22
Current: $0.94
Upside: +2,242.42%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $9.08
Upside: +858.15%
Jan 27, 2023
Initiates: Overweight
Price Target: $94
Current: $14.40
Upside: +552.78%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $18.20
Upside: +861.54%
Aug 12, 2022
Initiates: Overweight
Price Target: $10
Current: $0.81
Upside: +1,138.54%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $49.86
Upside: +44.40%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $12.73
Upside: +112.10%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $7.98
Upside: +138.10%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $1.72
Upside: +2,806.98%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $2.22
Upside: +1,701.80%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.61
Upside: +2,861.50%
Aug 26, 2020
Initiates: Overweight
Price Target: $21
Current: $0.49
Upside: +4,147.57%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $16.17
Upside: +376.19%
Aug 26, 2020
Initiates: Overweight
Price Target: $26
Current: $4.32
Upside: +501.85%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $43.69
Upside: +76.24%